Style | Citing Format |
---|---|
MLA | Zobeiri M, et al.. "Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases." Current Pharmaceutical Biotechnology, vol. 21, no. 13, 2020, pp. 1342-1353. |
APA | Zobeiri M, Momtaz S, Parvizi F, Tewari D, Farzaei MH, Nabavi SM (2020). Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases. Current Pharmaceutical Biotechnology, 21(13), 1342-1353. |
Chicago | Zobeiri M, Momtaz S, Parvizi F, Tewari D, Farzaei MH, Nabavi SM. "Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases." Current Pharmaceutical Biotechnology 21, no. 13 (2020): 1342-1353. |
Harvard | Zobeiri M et al. (2020) 'Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases', Current Pharmaceutical Biotechnology, 21(13), pp. 1342-1353. |
Vancouver | Zobeiri M, Momtaz S, Parvizi F, Tewari D, Farzaei MH, Nabavi SM. Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases. Current Pharmaceutical Biotechnology. 2020;21(13):1342-1353. |
BibTex | @article{ author = {Zobeiri M and Momtaz S and Parvizi F and Tewari D and Farzaei MH and Nabavi SM}, title = {Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases}, journal = {Current Pharmaceutical Biotechnology}, volume = {21}, number = {13}, pages = {1342-1353}, year = {2020} } |
RIS | TY - JOUR AU - Zobeiri M AU - Momtaz S AU - Parvizi F AU - Tewari D AU - Farzaei MH AU - Nabavi SM TI - Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases JO - Current Pharmaceutical Biotechnology VL - 21 IS - 13 SP - 1342 EP - 1353 PY - 2020 ER - |